Cargando…

Distinct Effects of Non-absorbed Agents Rifaximin and Berberine on the Microbiota-Gut-Brain Axis in Dysbiosis-induced Visceral Hypersensitivity in Rats

BACKGROUND/AIMS: Irritable bowel syndrome (IBS) is accepted as a disorder of gut-brain interactions. Berberine and rifaximin are non-absorbed antibiotics and have been confirmed effective for IBS treatment, but there is still lack of direct comparison of their effects. This study aims to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jindong, Zhang, Cunzheng, Zhang, Tao, Zhang, Lu, Duan, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Neurogastroenterology and Motility 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577460/ https://www.ncbi.nlm.nih.gov/pubmed/37814439 http://dx.doi.org/10.5056/jnm22182

Ejemplares similares

“Sentinel or accomplice”: gut microbiota and microglia crosstalk in disorders of gut–brain interaction
por: Zheng, Haonan, et al.
Publicado: (2023)

Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation
por: Zhang, Jin-dong, et al.
Publicado: (2021)

Transforming berberine into its intestine-absorbable form by the gut microbiota
por: Feng, Ru, et al.
Publicado: (2015)

Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)
por: Guo, Huaizhu, et al.
Publicado: (2023)

Berberine prevents stress-induced gut inflammation and visceral hypersensitivity and reduces intestinal motility in rats
por: Yu, Zhi-Chao, et al.
Publicado: (2019)

Beneficial effect of butyrate‐producing Lachnospiraceae on stress‐induced visceral hypersensitivity in rats
por: Zhang, Jindong, et al.
Publicado: (2018)

Berberine Suppresses Lung Metastasis of Cancer via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1
por: Tian, Wenjia, et al.
Publicado: (2022)

Sialic acid exacerbates gut dysbiosis-associated mastitis through the microbiota-gut-mammary axis by fueling gut microbiota disruption
por: Zhao, Caijun, et al.
Publicado: (2023)

Antibiotic-Induced Dysbiosis of the Gut Microbiota Impairs Gene Expression in Gut-Liver Axis of Mice
por: Liu, Pu, et al.
Publicado: (2023)

Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation
por: Zhou, Chunhua, et al.
Publicado: (2020)

Human Gut Microbiota: Dysbiosis and Manipulation
por: Shen, Dongqian, et al.
Publicado: (2012)

Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis
por: Zhang, Tao, et al.
Publicado: (2022)

Fusobacterium nucleatum Causes Microbial Dysbiosis and Exacerbates Visceral Hypersensitivity in a Colonization-Independent Manner
por: Gu, Xiang, et al.
Publicado: (2020)

Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially
por: Jia, Qiong, et al.
Publicado: (2019)

Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation
por: Ponziani, Francesca Romana, et al.
Publicado: (2017)

Effects of Rifaximin on Luminal and Wall-Adhered Gut Commensal Microbiota in Mice
por: Ferrer, Marina, et al.
Publicado: (2021)

Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression
por: Liu, Yiyun, et al.
Publicado: (2021)

Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis
por: Wang, Ben, et al.
Publicado: (2020)

The effect of gut microbiota dysbiosis on patients with preeclampsia
por: Zhao, Yefang, et al.
Publicado: (2023)

Dysbiosis of the gut microbiota in disease
por: Carding, Simon, et al.
Publicado: (2015)

Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)

The prophylactic effects of BIFICO on the antibiotic-induced gut dysbiosis and gut microbiota
por: Wu, Jiannong, et al.
Publicado: (2020)

Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders
por: Kandpal, Meenakshi, et al.
Publicado: (2022)

Features of Gut Microbiome Associated With Responses to Fecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review
por: Zhang, Jindong, et al.
Publicado: (2022)

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome
por: Liu, Rui, et al.
Publicado: (2017)

Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
por: Zhang, Xu, et al.
Publicado: (2015)

Dysbiosis characteristics of gut microbiota in cerebral infarction patients
por: Li, Hao, et al.
Publicado: (2020)

Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species
por: Yukawa‐Muto, Yoshimi, et al.
Publicado: (2022)

Corrigendum: The effect of gut microbiota dysbiosis on patients with preeclampsia
por: Zhao, Yefang, et al.
Publicado: (2023)

Gut microbiota dysbiosis contributes to the development of hypertension
por: Li, Jing, et al.
Publicado: (2017)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Periodontitis may induce gut microbiota dysbiosis via salivary microbiota
por: Bao, Jun, et al.
Publicado: (2022)

Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson’s Disease
por: Kaur, Gagandeep, et al.
Publicado: (2021)

Rifaximin Modifies Gut Microbiota and Attenuates Inflammation in Parkinson’s Disease: Preclinical and Clinical Studies
por: Hong, Chien-Tai, et al.
Publicado: (2022)

Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota
por: Wang, Ming-Wei, et al.
Publicado: (2023)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Gut Microbiota Dysbiosis in Functional Dyspepsia
por: Tziatzios, Georgios, et al.
Publicado: (2020)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Development of the gut microbiota and dysbiosis in children
por: AKAGAWA, Shohei, et al.
Publicado: (2020)

Fungal gut microbiota dysbiosis in systemic lupus erythematosus
por: Yang, Ping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88vupgq8otkqrgjt42pff8rghs